General Information of the Cell Line
Cell Line ID
CL000163
Cell Line Name
COLO 205
Synonyms
Colo 205
CoLo 205
COLO-205
Colo-205
COLO.205
Colo205
COLO205
Co 205
Colorado 205
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0218
Tissue Information
Ascites
Disease
Colon adenocarcinoma (NCIt: C4349)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01080, ERK activator kinase 1
Compound ID Compound Name Compound Formula
CP0158653
Pimasertib
   Show/Hide
C15H15FIN3O3
 1
1
IC50 = 1.81 nM
   TI
   LI
   LO
   TS
CP0116312
2-[(2S)-2,3-dihydroxypropyl]-8-(2-fluoro-4-iodoanilino)pyrido[3,4-d]pyridazin-1-one
   Show/Hide
C16H14FIN4O3
 1
1
IC50 = 1.95 nM
   TI
   LI
   LO
   TS
CP0382258
N-[(2S)-2,3-dihydroxypropyl]-5-(2-fluoro-4-iodoanilino)pyrimidine-4-carboxamide
   Show/Hide
C14H14FIN4O3
 1
1
IC50 = 3.41 nM
   TI
   LI
   LO
   TS
CP0027641
(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
   Show/Hide
C17H15F2IN4O4
 1
1
IC50 = 6.92 nM
   TI
   LI
   LO
   TS
CP0550678
2-[(2S)-2,3-dihydroxypropyl]-8-(2-fluoro-4-iodoanilino)-4-methylpyrido[3,4-d]pyridazin-1-one
   Show/Hide
C17H16FIN4O3
 1
1
IC50 = 13.9 nM
   TI
   LI
   LO
   TS
CP0273467
2-chloro-N-[(2S)-2,3-dihydroxypropyl]-5-(2-fluoro-4-iodoanilino)pyrimidine-4-carboxamide
   Show/Hide
C14H13ClFIN4O3
 1
1
IC50 = 44.3 nM
   TI
   LI
   LO
   TS
CP0571209
N-(1,3-dihydroxypropan-2-yl)-5-(2-fluoro-4-iodoanilino)pyrimidine-4-carboxamide
   Show/Hide
C14H14FIN4O3
 1
1
IC50 = 55.2 nM
   TI
   LI
   LO
   TS
CP0554907
N-[(2R)-2,3-dihydroxypropyl]-5-(2-fluoro-4-iodoanilino)pyrimidine-4-carboxamide
   Show/Hide
C14H14FIN4O3
 1
1
IC50 = 56.6 nM
   TI
   LI
   LO
   TS
CP0273468
5-(2-fluoro-4-iodoanilino)-N-(3-hydroxypropyl)pyrimidine-4-carboxamide
   Show/Hide
C14H14FIN4O2
 1
1
IC50 = 101.4 nM
   TI
   LI
   LO
   TS
CP0113690
5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethyl)pyrimidine-4-carboxamide
   Show/Hide
C13H12FIN4O2
 1
1
IC50 = 101.6 nM
   TI
   LI
   LO
   TS
CP0317919
3-[(2S)-2,3-dihydroxypropyl]-5-(2-fluoro-4-iodoanilino)pyrido[3,4-d]pyrimidin-4-one
   Show/Hide
C16H14FIN4O3
 1
1
IC50 = 108 nM
   TI
   LI
   LO
   TS
CP0095543
3-[(2R)-2,3-dihydroxypropyl]-5-(2-fluoro-4-iodoanilino)pyrido[3,4-d]pyrimidin-4-one
   Show/Hide
C16H14FIN4O3
 1
1
IC50 = 142 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0000866
6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one Hydrochloride
   Show/Hide
C24H29N7O2  1
1
IC50 = 36 nM
   TI
   LI
   LO
   TS
CP0003433
(Arylindolyl)maleimide deriv. 27
   Show/Hide
C21H16N4O2  1
1
GI50 = 1690 nM
   TI
   LI
   LO
   TS
CP0006321
PLX-4032
   Show/Hide
C23H18ClF2N3O3S  1
1
EC50 = 240 nM
   TI
   LI
   LO
   TS
CP0007711
(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-N'-propylprop-2-enehydrazide;2,2,2-trifluoroacetic acid
   Show/Hide
C26H31F3N4O3  1
1
GI50 = 29.8 nM
   TI
   LI
   LO
   TS
CP0010682
2-((6-amino-9H-purin-9-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one
   Show/Hide
C22H19N7O  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0011213
4,5-dimethoxy-9-oxo-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaene-14-carbonitrile
   Show/Hide
C19H15N3O3  1
1
IC50 = 470 nM
   TI
   LI
   LO
   TS
CP0016389
6-(1-ethylpiperidin-4-yl)-N-[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]-7,8-dihydro-5H-1,6-naphthyridin-2-amine
   Show/Hide
C30H36F2N8  1
1
IC50 = 57 nM
   TI
   LI
   LO
   TS
CP0016713
2-[(E)-2-(2,6-dichlorophenyl)ethenyl]-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one
   Show/Hide
C23H21Cl2NO5  1
1
GI50 = 7000 nM
   TI
   LI
   LO
   TS
CP0019438
8-[3-(1-benzothiophen-2-yl)-5-chloropyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one
   Show/Hide
C21H20ClN3OS  1
1
GI50 > 50000 nM
   TI
   LI
   LO
   TS
CP0019439
8-[3-(1-benzofuran-2-yl)-5-chloropyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one
   Show/Hide
C21H20ClN3O2  1
1
GI50 > 50000 nM
   TI
   LI
   LO
   TS
CP0037781
3-[3-(azetidin-1-ylmethyl)cyclobutyl]-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine
   Show/Hide
C29H28N6  1
1
IC50 = 930 nM
   TI
   LI
   LO
   TS
CP0064592
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
   Show/Hide
C47H51NO14  1
1
GI50 = 7.9 nM
   TI
   LI
   LO
   TS
CP0082019
(2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid
   Show/Hide
C22H21NO2S  1
1
GI50 = 3160 nM
   TI
   LI
   LO
   TS
CP0086475
2-[(4-methoxyphenyl)-diphenylmethyl]sulfanylethanamine
   Show/Hide
C22H23NOS  1
1
GI50 = 210 nM
   TI
   LI
   LO
   TS
CP0091315
US9422297, AAG145-136
   Show/Hide
C17H13ClN4  1
1
GI50 = 638 nM
   TI
   LI
   LO
   TS
CP0104718
2,6-difluoro-N-(3-methoxy-1H-pyrazolo[3,4-b]pyridin-5-yl)-3-(propylsulfonylamino)benzamide
   Show/Hide
C17H17F2N5O4S  1
1
EC50 = 80 nM
   TI
   LI
   LO
   TS
CP0166079
6-hydroxy-N-[[4-(methanesulfonamidomethyl)phenyl]methyl]-N-methyl-3-[(3-methylphenyl)methyl]-2H-indazole-5-carboxamide
   Show/Hide
C26H28N4O4S  1
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0238038
6-(5-methyl-1H-pyrazol-4-yl)-2-(pyrrolidin-1-ylmethyl)-3H-thieno[3,2-d]pyrimidin-4-one
   Show/Hide
C15H17N5OS  1
1
EC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0370065
5-(4-chlorophenyl)-2-(4-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazole
   Show/Hide
C17H12ClN3OS  1
1
LC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0383276
N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine
   Show/Hide
C16H17N3O2  1
1
GI50 = 20 nM
   TI
   LI
   LO
   TS
CP0521699
6-(1H-pyrazol-4-yl)-2-(pyrrolidin-1-ylmethyl)-3H-thieno[3,2-d]pyrimidin-4-one
   Show/Hide
C14H15N5OS  1
1
EC50 = 7500 nM
   TI
   LI
   LO
   TS
CP0572493
N-[4-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclohexyl]cyclohexanecarboxamide
   Show/Hide
C33H45N7O3  1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0897293
1-(7-Benzyl-2-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)-6-methoxy-1,2,3,4-tetrahydroquinoline hydrochloride
   Show/Hide
C24H25ClN4O  1
1
GI50 = 232 nM
   TI
   LI
   LO
   TS
CP0906523
7-Benzyl-N-(4-methoxyphenyl)-N,2,5-trimethyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride
   Show/Hide
C23H25ClN4O  1
1
GI50 = 26.3 nM
   TI
   LI
   LO
   TS
CP0931559
2-[(Dimethylamino)methyl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one dihydrochloride
   Show/Hide
C13H17Cl2N5OS  1
1
EC50 = 3200 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Ascites)
Cell Line Name Organism Disease
PEO1 Homo sapiens (Human) BRCA2-associated hereditary breast and ovarian cancer syndrome
MAST Homo sapiens (Human) Breast carcinoma
Ramos Homo sapiens (Human) Burkitt lymphoma
CA46 Homo sapiens (Human) Burkitt lymphoma
CellSensor STAT6-bla RA-1 Homo sapiens (Human) Burkitt lymphoma
NCI-H716 Homo sapiens (Human) Cecum adenocarcinoma
COLO 201 Homo sapiens (Human) Colon adenocarcinoma
DiFi Homo sapiens (Human) Colorectal carcinoma
U-2932 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
DB Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
HEC-50B Homo sapiens (Human) Endometrial adenocarcinoma
SNU-5 Homo sapiens (Human) Gastric adenocarcinoma
SNU-16 Homo sapiens (Human) Gastric adenocarcinoma
SNU-620 Homo sapiens (Human) Gastric adenocarcinoma
SNU-638 Homo sapiens (Human) Gastric adenocarcinoma
SNU-668 Homo sapiens (Human) Gastric signet ring cell adenocarcinoma
OVCAR-3 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
OVCAR-5 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
COV318 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
ZR-75-1 Homo sapiens (Human) Invasive breast carcinoma of no special type
SK-HEP-1 Homo sapiens (Human) Liver and intrahepatic bile duct epithelial neoplasm
OV-90 Homo sapiens (Human) Ovarian adenocarcinoma
LK2 Homo sapiens (Human) Ovarian carcinoma
RMG-I Homo sapiens (Human) Ovarian clear cell adenocarcinoma
PA-1 Homo sapiens (Human) Ovarian mixed germ cell tumor
SK-OV-3 Homo sapiens (Human) Ovarian serous cystadenocarcinoma
SKOV3/TR Homo sapiens (Human) Ovarian serous cystadenocarcinoma
AsPC-1 Homo sapiens (Human) Pancreatic ductal adenocarcinoma
HEC Homo sapiens (Human) Peritoneal malignant mesothelioma
Ehrlich-Lettre ascites strain E Mus musculus (Mouse) Malignant neoplasms of the mouse mammary gland
RAW 264.7 Mus musculus (Mouse) Mouse leukemia
L1210 Mus musculus (Mouse) Mouse leukemia
L1210/R81 Mus musculus (Mouse) Mouse leukemia
RAW-Lucia ISG Mus musculus (Mouse) Mouse leukemia
RAW-Lucia ISG-KO-STING Mus musculus (Mouse) Mouse leukemia
RAW 264 Mus musculus (Mouse) Mouse leukemia
J774 Mus musculus (Mouse) Mouse reticulum cell sarcoma
J774A1 Mus musculus (Mouse) Mouse reticulum cell sarcoma
HTC Rattus norvegicus (Rat) Rat hepatocellular carcinoma